Published in Mol Biochem Parasitol on May 01, 1983
Patterns of gene-specific and total transcriptional activity during the Plasmodium falciparum intraerythrocytic developmental cycle. Eukaryot Cell (2009) 1.05
Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (1984) 0.93
A global measure of perceived stress. J Health Soc Behav (1983) 56.90
Stress, social support, and the buffering hypothesis. Psychol Bull (1985) 19.28
Socioeconomic status and health. The challenge of the gradient. Am Psychol (1994) 13.59
Epidermal growth factor. Annu Rev Biochem (1979) 11.82
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol (1976) 10.88
Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J Biol Chem (1972) 10.86
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med (1997) 8.65
Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem (1980) 7.71
Beta Alanine as a Growth Accessory for the Diphtheria Bacillus. J Bacteriol (1937) 7.51
Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci U S A (1978) 5.91
Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J Cell Biol (1979) 5.62
Does hiatus hernia affect competence of the gastroesophageal sphincter? N Engl J Med (1971) 5.44
Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem (1980) 5.19
Epidermal growth factor. J Biol Chem (1990) 4.79
Prophylactic vs therapeutic blood patch for obstetric patients with accidental dural puncture--a randomised controlled trial. Anaesthesia (2014) 4.75
IMMUNITY IN MUMPS : II. THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY AND DERMAL HYPERSENSITIVITY IN HUMAN BEINGS FOLLOWING MUMPS. J Exp Med (1945) 4.69
The primary structure of epidermal growth factor. J Biol Chem (1972) 4.41
Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc Natl Acad Sci U S A (1978) 4.03
Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol (1976) 3.91
A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem (1982) 3.81
IN VITRO AND IN VIVO EFFECTS OF A NERVE GROWTH-STIMULATING AGENT ISOLATED FROM SNAKE VENOM. Proc Natl Acad Sci U S A (1956) 3.64
THE INFLUENCE OF PROTEIN INTAKE ON THE UREA CLEARANCE IN NORMAL MAN. J Clin Invest (1934) 3.60
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature (1976) 3.56
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature (1978) 3.54
Hormone receptor topology and dynamics: morphological analysis using ferritin-labeled epidermal growth factor. Proc Natl Acad Sci U S A (1979) 3.54
Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature (2000) 3.51
Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J Biol Chem (1975) 3.48
Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol (1994) 3.36
Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science (1993) 3.30
Heterogeneity of the peptide chains of gamma-globulin. Biochem J (1964) 3.25
Action of malarial antibody in vitro. Nature (1969) 3.24
Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J Biol Chem (1979) 3.18
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun (1982) 3.01
ABC of intensive care. Withdrawal of treatment. BMJ (1999) 2.96
Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci U S A (1975) 2.95
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Social support and smoking cessation and maintenance. J Consult Clin Psychol (1986) 2.92
Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J Cell Biol (1979) 2.88
The production of migration inhibition factor by B and T cells of the guinea pig. J Exp Med (1973) 2.86
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet (1999) 2.83
Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen. Parasite Immunol (1988) 2.79
In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Antimicrob Agents Chemother (1976) 2.75
Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol (1989) 2.72
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med (2000) 2.70
Properties of protective malarial antibody. Immunology (1970) 2.65
Rapid induction of morphological changes in human carcinoma cells A-431 by epidermal growth factors. J Cell Biol (1979) 2.61
Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect Immun (2004) 2.59
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol Biochem Parasitol (1984) 2.54
A simple technique to reduce the incidence of accidental dural puncture. Anaesthesia (2001) 2.53
Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem (2001) 2.53
Stress and immunity in humans: a meta-analytic review. Psychosom Med (1993) 2.52
Conjugational transfer of gentamicin resistance plasmids intra- and interspecifically in Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (1983) 2.50
The distribution of antigenic and nonantigenic compounds within draining lymph nodes. Lab Invest (1966) 2.49
Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis (1980) 2.48
Enhancement of calcium uptake and phosphatidylinositol turnover by epidermal growth factor in A-431 cells. Biochemistry (1981) 2.46
Social support and adjustment to cancer: reconciling descriptive, correlational, and intervention research. Health Psychol (1996) 2.46
Precise timing of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization. J Biol Chem (1998) 2.44
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Inconsistent visual analyses of intrasubject data. J Appl Behav Anal (1979) 2.43
A merozoite vaccine effective against Plasmodium knowlesi malaria. Nature (1974) 2.39
Group support interventions for women with breast cancer: who benefits from what? Health Psychol (2000) 2.38
In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med (1971) 2.36
Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax (1998) 2.33
Depression and immunity: a meta-analytic review. Psychol Bull (1993) 2.30
Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection. Infect Immun (2000) 2.29
Investigation of benefits and costs of an ophthalmic outreach clinic in general practice. Br J Gen Pract (1995) 2.26
Absence of circular plasmid deoxyribonucleic acid attributable to a genetic determinant for methicillin resistance in Staphylococcus aureus. J Bacteriol (1973) 2.25
Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation (2000) 2.25
Our new President: Frank P. Brooks. Gastroenterology (1980) 2.24
Cytoplasmic pH regulation in thymic lymphocytes by an amiloride-sensitive Na+/H+ antiport. J Gen Physiol (1984) 2.23
In vitro isolation of Plasmodium knowlesi merozoites using polycarbonate sieves. Parasitology (1975) 2.23
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci U S A (2001) 2.21
Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology (1978) 2.21
Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. J Biol Chem (1984) 2.21
Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol Biochem Parasitol (2000) 2.21
Merozoite vaccination against Plasmodium knowlesi malaria. Immunology (1975) 2.21
A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev (2001) 2.18
Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. AJNR Am J Neuroradiol (2001) 2.16
Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA. Mol Biochem Parasitol (2000) 2.12
Structure and biological properties of immunoglobulins. Adv Immunol (1967) 2.08
Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin. J Clin Invest (1971) 2.07
Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology (1976) 2.05
Constitutive penicillinase formation in Staphylococcus aureus owing to a mutation unlinked to the penicillinase plasmid. J Bacteriol (1968) 2.03
A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. J Biol Chem (1990) 2.02
The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun (1998) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Transfection of malaria parasites. Methods (1997) 1.99
Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin Exp Immunol (1982) 1.97
Merozoite vaccination of douroucouli monkeys against falciparum malaria. Lancet (1977) 1.95
Effect of the prophage and penicillinase plasmid of the recipient strain upon the transduction and the stability of methicillin resistance in Staphylococcus aureus. J Bacteriol (1973) 1.92